Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Louis Harkell
Chinese animal health firms were not unscathed by African swine fever (ASF) in 2018 but the disease arrived too late in the calendar year for it to seriously trouble companies' full-year results. However, pressure started to emerge in the first-half of 2019, Animal Pharm correspondent Louis Harkell reports.
A recent survey by the Chinese Veterinary Medicines Association (CVMA) underscores the challenges facing the country's domestic animal health sector. Animal Pharm's China correspondent Louis Harkell delves deeper into the industry's major growth geography.
China's largest market-listed animal health companies had a mixed year in fiscal 2017, as big sector changes continue to shake up the country's veterinary medicines market. Animal Pharm correspondent Louis Harkell explored the issues impacting one of the world's top-growth animal health markets.
China's largest domestic animal health company has blamed the withdrawal of two swine vaccinations from the country's compulsory scheme for a decline in its veterinary biological sales.
China’s national milk production output has declined for the second year running. However, a rise in imports on the back of this is unlikely, according to a leading analyst.
After the Huishan Dairy debacle, question marks hang over another Chinese milk producer’s massive profits as national milk production falls.